Skip to Content

Viemed overcomes headwinds

Viemed overcomes headwinds

Casey HoytLAFAYETTE, La. – Viemed Healthcare reported net revenues of $27.8 million that are attributable to the company’s core business, a 12% increase compared to the same period last year and a 6% increase compared to the second quarter. 

Total net revenues for the third quarter were $29.3 million, including $1.5 million in net revenues for contact and vaccine tracing services and product sales related to the COVID-19 pandemic. 

“We are excited to report another record-breaking quarter despite headwinds associated with the Delta variant,” said Casey Hoyt, CEO of Viemed. “The resiliency of our workforce and the strength of our relationship has driven our continued grow during these unprecedented times.” 

Viemed reported net income of $1.8 million for the third quarter this year vs. $2.8 million for the same period last year. 

The company says it grew its ventilator patient count to 8,200 by Sept. 30, 2021, compared to 8,103, by June 30, 2021. 

“The nationwide sales training programs conducted during the previous quarter have concluded and are expected to give our sales force new products to add to our superior service model,” Hoyt said. “As we look forward, we continue to believe that our ability to provide technology enabled health care in the home setting will create enormous value and positive patient outcomes.” 

Viemed expects to generate net revenues of about $27.8 million to $28.8 million that are attributable to its core business during the fourth quarter. 


To comment on this post, please log in to your account or set up an account now.